Potential of Salivary Matrix Metalloproteinase 9 to Discriminate Periodontal health and disease
Main Article Content
Periodontitis is a chronic inflammatory disease resulted from aggravated immune response to a dysbiotic subgingival microbiota of a susceptible host. Consequences of periodontitis are not only limited to the devastating effect on the oral cavity but extends to affect general health of the individual and also exerts economic burdens on the health systems worldwide. Despite these serious outcomes of periodontitis; however, they are avoidable by early diagnosis with proper preventive measures or non-invasive interventions at earlier stages of the disease. Clinically, diagnosis of periodontitis could be overlooked due to certain limitations of the conventional diagnostic methods such as periodontal charting and radiographs. Utilization of readily available biomarkers in the oral biofluids represents a potential opportunity to overcome these issues. This topic received great attention in the last decades and one of these biomarkers is matrix metalloproteinase 9 which is highlighted in this review as one of the candidates that can be used for diagnosis of periodontal diseases
Received date: 15-3-2022
Accepted date: 14-5-2022
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licenses and Copyright
The following policy applies in The Journal of Baghdad College of Dentistry (JBCD):
# JBCD applies the Creative Commons Attribution (CC BY) license to articles and other works we publish. If you submit your paper for publication by JBCD, you agree to have the CC BY license applied to your work. Under this Open Access license, you as the author agree that anyone can reuse your article in whole or part for any purpose, for free, even for commercial purposes. Anyone may copy, distribute, or reuse the content as long as the author and original source are properly cited. This facilitates freedom in re-use and also ensures that JBCD content can be mined without barriers for the needs of research.
# If your manuscript contains content such as photos, images, figures, tables, audio files, videos, etc., that you or your co-authors do not own, we will require you to provide us with proof that the owner of that content (a) has given you written permission to use it, and (b) has approved of the CC BY license being applied to their content. We provide a form you can use to ask for and obtain permission from the owner. If you do not have owner permission, we will ask you to remove that content and/or replace it with other content that you own or have such permission to use.Don't assume that you can use any content you find on the Internet, or that the content is fair game just because it isn't clear who the owner is or what license applies.
# Many authors assume that if they previously published a paper through another publisher, they own the rights to that content and they can freely use that content in their paper, but thatâ€™s not necessarily the case, it depends on the license that covers the other paper. Some publishers allow free and unrestricted re-use of article content they own, such as under the CC BY license. Other publishers use licenses that allow re-use only if the same license is applied by the person or publisher re-using the content. If the paper was published under a CC BY license or another license that allows free and unrestricted use, you may use the content in your JBCD paper provided that you give proper attribution, as explained above.If the content was published under a more restrictive license, you must ascertain what rights you have under that license. At a minimum, review the license to make sure you can use the content. Contact that JBCD if you have any questions about the license. If the license does not permit you to use the content in a paper that will be covered by an unrestricted license, you must obtain written permission from the publisher to use the content in your JBCD paper. Please do not include any content in your JBCD paper which you do not have rights to use, and always give proper attribution.
# If any relevant accompanying data is submitted to repositories with stated licensing policies, the policies should not be more restrictive than CC BY.
# JBCD reserves the right to remove any photos, captures, images, figures, tables, illustrations, audio and video files, and the like, from any paper, whether before or after publication, if we have reason to believe that the content was included in your paper without permission from the owner of the content.
Kinane DF, Stathopoulou PG and Papapanou PN. Periodontal diseases. Nat Rev Dis Primers. 2017;3:17038.
Botelho J, Machado V, Leira Y, Proença L, Chambrone L and Mendes JJ. Economic burden of periodontitis in the United States and Europe: An updated estimation. J Periodontol. 2022;93:373-379.
Kornman KS. Mapping the pathogenesis of periodontitis: a new look. J Periodontol. 2008;79:1560-8.
Nazir M, Al-Ansari A, Al-Khalifa K, Alhareky M, Gaffar B and Almas K. Global Prevalence of Periodontal Disease and Lack of Its Surveillance. ScientificWorldJournal. 2020;2020:2146160.
Darveau RP. Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol. 2010;8:481-90.
Offenbacher S. Periodontal diseases: pathogenesis. Ann Periodontol. 1996;1:821-78.
Weng H, Yan Y, Jin YH, Meng XY, Mo YY and Zeng XT. Matrix metalloproteinase gene polymorphisms and periodontitis susceptibility: a meta-analysis involving 6,162 individuals. Sci Rep. 2016;6:24812.
Romanos GE and Bernimoulin JP. [Collagen as a basic element of the periodontium: immunohistochemical aspects in the human and animal. 1. Gingiva and alveolar bone]. Parodontol. 1990;1:363-75.
Murphy G. Tissue inhibitors of metalloproteinases. Genome Biol. 2011;12:233.
Checchi V, Maravic T, Bellini P, Generali L, Consolo U, Breschi L and Mazzoni A. The Role of Matrix Metalloproteinases in Periodontal Disease. Int J Environ Res Public Health. 2020;17.
Caton JG, Armitage G, Berglundh T, Chapple ILC, Jepsen S, Kornman KS, Mealey BL, Papapanou PN, Sanz M and Tonetti MS. A new classification scheme for periodontal and peri-implant diseases and conditions - Introduction and key changes from the 1999 classification. J Periodontol. 2018;89 Suppl 1:S1-s8.
Slots J. Periodontitis: facts, fallacies and the future. Periodontol 2000. 2017;75:7-23.
Andrade R, Espinoza M, Gómez EM, Espinoza JR and Cruz E. Intra- and inter-examiner reproducibility of manual probing depth. Braz Oral Res. 2012;26:57-63.
Lafzi A, Mohammadi AS, Eskandari A and Pourkhamneh S. Assessment of Intra- and Inter-examiner Reproducibility of Probing Depth Measurements with a Manual Periodontal Probe. J Dent Res Dent Clin Dent Prospects. 2007;1:19-25.
Papapanou PN, Sanz M, Buduneli N, Dietrich T, Feres M, Fine DH, Flemmig TF, Garcia R, Giannobile WV, Graziani F, Greenwell H, Herrera D, Kao RT, Kebschull M, Kinane DF, Kirkwood KL, Kocher T, Kornman KS, Kumar PS, Loos BG, Machtei E, Meng H, Mombelli A, Needleman I, Offenbacher S, Seymour GJ, Teles R and Tonetti MS. Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol. 2018;89 Suppl 1:S173-s182.
Shaddox LM and Walker CB. Treating chronic periodontitis: current status, challenges, and future directions. Clin Cosmet Investig Dent. 2010;2:79-91.
Kim HD, Sukhbaatar M, Shin M, Ahn YB and Yoo WS. Validation of periodontitis screening model using sociodemographic, systemic, and molecular information in a Korean population. J Periodontol. 2014;85:1676-83.
Chen Q, Jin M, Yang F, Zhu J, Xiao Q and Zhang L. Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling. Mediators Inflamm. 2013;2013:928315.
Jotwani R, Eswaran SV, Moonga S and Cutler CW. MMP-9/TIMP-1 imbalance induced in human dendritic cells by Porphyromonas gingivalis. FEMS Immunol Med Microbiol. 2010;58:314-21.
Xie R, Kuijpers-Jagtman AM and Maltha JC. Osteoclast differentiation and recruitment during early stages of experimental tooth movement in rats. Eur J Oral Sci. 2009;117:43-50.
Somerville RP, Oblander SA and Apte SS. Matrix metalloproteinases: old dogs with new tricks. Genome Biol. 2003;4:216.
Delaissé JM, Andersen TL, Engsig MT, Henriksen K, Troen T and Blavier L. Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities. Microsc Res Tech. 2003;61:504-13.
Şurlin P, Oprea B, Solomon SM, Popa SG, Moţa M, Mateescu GO, Rauten AM, Popescu DM, Dragomir LP, Puiu I, Bogdan M and Popescu MR. Matrix metalloproteinase -7, -8, -9 and -13 in gingival tissue of patients with type 1 diabetes and periodontitis. Rom J Morphol Embryol. 2014;55:1137-41.
Kc S, Wang XZ and Gallagher JE. Diagnostic sensitivity and specificity of host-derived salivary biomarkers in periodontal disease amongst adults: Systematic review. J Clin Periodontol. 2020;47:289-308.
de Morais EF, Pinheiro JC, Leite RB, Santos PPA, Barboza CAG and Freitas RA. Matrix metalloproteinase-8 levels in periodontal disease patients: A systematic review. J Periodontal Res. 2018;53:156-163.
Victor DJ, Subramanian S, Gnana PP and Kolagani SP. Assessment of Matrix Metalloproteinases-8 and -9 in Gingival Crevicular Fluid of Smokers and Non-smokers with Chronic Periodontitis Using ELISA. J Int Oral Health. 2014;6:67-71.
Saglam M, Kantarci A, Dundar N and Hakki SS. Clinical and biochemical effects of diode laser as an adjunct to nonsurgical treatment of chronic periodontitis: a randomized, controlled clinical trial. Lasers Med Sci. 2014;29:37-46.
Bostanci N, Mitsakakis K, Afacan B, Bao K, Johannsen B, Baumgartner D, Müller L, Kotolová H, Emingil G and Karpíšek M. Validation and verification of predictive salivary biomarkers for oral health. Sci Rep. 2021;11:6406.
Kim H-D, Lee C-S, Cho H-J, Jeon S, Choi Y-N, Kim S, Kim D, Jin Lee H, Vu H, Jeong H-J and Kim B. Diagnostic ability of salivary matrix metalloproteinase-9 lateral flow test point-of-care test for periodontitis. J Clin Periodontol. 2020;47:1354-1361.
Kim. HD, Kim S, Jeon S, Kim SJ, Cho HJ and Choi YN. Diagnostic and Prognostic ability of salivary MMP-9 and S100A8 for periodontitis. J Clin Periodontol. 2020;47:1191-1200.
Alassiri S, Parnanen P, Rathnayake N, Johannsen G, Heikkinen AM, Lazzara R, van der Schoor P, van der Schoor JG, Tervahartiala T, Gieselmann D and Sorsa T. The Ability of Quantitative, Specific, and Sensitive Point-of-Care/Chair-Side Oral Fluid Immunotests for aMMP-8 to Detect Periodontal and Peri-Implant Diseases. Dis Markers. 2018;2018:1306396.